Compound Detail
CHEMBL4130229
VODOBATINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL4130229 |
| Name | VODOBATINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | ZQOBVMHBVWNVBG-UHFFFAOYSA-N |
3
Targets
5
Activities
1
Assay Types
0
PK Parameters
5
Publications
4
Known Names
5
Indications
2
Mechanisms
Molecular Properties
453.9
MW (Da)
4.98
ALogP
3
HBA
2
HBD
71.1
PSA (Ų)
0.33
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase ABL inhibitor | INHIBITOR | Tyrosine-protein kinase ABL1 | ✓ | ✓ |
| Bcr/Abl fusion protein inhibitor | INHIBITOR | Bcr/Abl fusion protein | ✓ | ✓ |
Indications
Dementia Parkinson Disease Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Neurodegenerative Diseases
Activity Summary
IC50 5 meas. best 9.05
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Bcr/Abl fusion protein CHEMBL2096618 | IC50 | 9.05 | 9.05 | 0.9 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.81 | 6.795 | 154.0 | 2 |
| BCR/ABL1 CHEMBL4523652 | IC50 | 6.78 | 6.245 | 165.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Bcr/Abl fusion protein | IC50 | = | 0.9 | nM | 9.05 | Inhibition of wild type BCR-ABL phosphorylation in mouse BaF3 cells incubated fo... | 35551036 |
| Unchecked | IC50 | = | 154.0 | nM | 6.81 | Inhibition of BCR-ABL Y253H mutant phosphorylation in mouse BaF3 cells incubated... | 35551036 |
| Unchecked | IC50 | = | 167.0 | nM | 6.78 | Inhibition of BCR-ABL L248R mutant phosphorylation in mouse BaF3 cells incubated... | 35551036 |
| BCR/ABL1 | IC50 | = | 165.0 | nM | 6.78 | Inhibition of BCR-ABL E255V mutant phosphorylation in mouse BaF3 cells incubated... | 35551036 |
| BCR/ABL1 | IC50 | = | 1967.0 | nM | 5.71 | Inhibition of BCR-ABL T315I mutant phosphorylation in mouse BaF3 cells incubated... | 35551036 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35551036 | 10.1016/j.ejmech.2022.114442 | ADMET | 3 |
| 35551036 | 10.1016/j.ejmech.2022.114442 | Unchecked | 2 |
| 35551036 | 10.1016/j.ejmech.2022.114442 | BCR/ABL1 | 2 |
| 29752185 | 10.1016/j.bmcl.2018.05.007 | ADMET | 1 |
| 35551036 | 10.1016/j.ejmech.2022.114442 | Bcr/Abl fusion protein | 1 |
Data from ChEMBL 36 via Core Engine